Human metapneumovirus (HMPV), a respiratory virus that causes flu-like symptoms, has attracted attention following a surge in cases in China.

HMPV was identified in 2001 and is known to cause mild to severe respiratory infections, particularly in vulnerable groups such as young children, the elderly and immunocompromised individuals.

Symptoms include fever, cough, nasal congestion and, in severe cases, complications such as bronchitis or pneumonia.

Social media videos showing overcrowded hospitals in China have heightened concerns around the world and are reminiscent of the early COVID-19 outbreak.

However, the Chinese government has assured citizens and tourists that the situation is under control. Mao Ning, a spokesman for China’s Foreign Ministry, attributed the increase to the winter season, saying: “Respiratory infections tend to peak during the winter season.” I can assure you that the Chinese government is concerned about the health of Chinese citizens and foreigners who coming to China is close to your heart. It is safe to travel in China.”

Is HMPV another COVID-19?

While comparisons between HMPV and SARS-CoV-2, the virus responsible for COVID-19, are inevitable, the two belong to different virus families. They share similarities in transmission, symptoms and groups at risk, but differ in the availability of vaccines and treatments.

Unlike COVID-19, for which there are vaccines and antiviral treatments such as Paxlovid, there is currently no vaccine or specific antiviral drugs for HMPV.

Dr. Atul Goel, an official at India’s Directorate General of Health Services (DGHS), clarified: “Metapneumovirus is like any other respiratory virus that causes a cold and can cause flu-like symptoms in very old and very young people.”

He stressed the need for general precautions such as: B. avoiding crowded places if you feel unwell and maintaining good hygiene.

How prepared is India?

India, which has faced significant challenges during the COVID-19 pandemic, is closely monitoring the situation. The National Center for Disease Control (NCDC) and DGHS have not confirmed any significant increase in respiratory outbreaks in the country.

Goel assured, “We have analyzed data on respiratory outbreaks in the country. There is no significant increase in the December 2024 data and no cases have been reported in large numbers by any of our institutions.”

Hospitals in India are equipped with supplies and beds to treat seasonal respiratory infections. Goel added: “One thing I would like to convey to the public is to adopt universal precautions that we take against all respiratory infections.”

What precautionary and preventative measures are there?

Experts emphasize the importance of preventative measures to contain the spread of HMPV:

• Wash your hands regularly and avoid close contact with sick people.

• Wearing masks in crowded places.

• Ensuring proper ventilation indoors.

Although HMPV is not currently a threat in India, vigilance and adherence to basic hygiene practices remain crucial. At this time, the global health community continues to monitor the situation and there is no need to panic.

By focusing on public awareness and preparedness, India will be better equipped to prevent a potential outbreak and ensure the safety of its citizens.

With input from agencies